INNT
TOTAL INVALIDATION PROCESSED BY THE IB
15/01/2022
Voltar para busca
Dado oficial do USPTO
BELIXOS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
58
Atualização mais recente
15/01/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
27/05/2009
Data de registro
06/04/2010
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/02/2021
Última transação
26/02/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
51377 Leverkusen, DE
Examinador
CORWIN, KEVIN
Unidade examinadora
M30
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Biofrontera Pharma GmbH
Biofrontera Pharma GmbH
Representantes
JENNIFER FRASER Dykema Gossett PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment and prevention of dermatological diseases and skin disorders; medicines for human purposespharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; medicines for veterinary purposespharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; chemical preparations for medical purposespharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; chemical preparations for veterinary purposesmedicines for the treatment of dermatological diseases and skin disorders; topical ointment and gels for the medical and therapeutic treatment of dermatological diseases and skin disorders; * all aforementioned goods not for the treatment of cancer and leukemia and the treatment of adverse effects of the treatment of cancer and leukemiain particular not for pharmaceutical preparations on the basis of mistletoe for the treatment of pre-cancerous lesionssolid tumorsmalignant hemoblastosesleukemiaslymphogranulomatosislymphomasplamacytomafor the stimulation of the bone marrow function and nutritional or dietary supplements * * all aforementioned goods not for the treatment of cancer and leukemia and the treatment of side-effects occurring during the treatment of cancer and leukemiaparticularly pharmaceutical preparations on the basis of mistletoes for the treatment of precancerous lesionssolid tumorsmalignant hemoblastosesleukemiaslymphogranulomatosislymphomasplasmacytomsfor stimulating the bone marrow functions and as nutritional supplements *
Publicações
Histórico de despachos e eventos da marca no USPTO.
58 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
19/12/2021
INPC
INVALIDATION PROCESSED
18/12/2021
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
26/10/2021
C71T
CANCELLED SECTION 71
26/02/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
13/06/2019
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
06/04/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/05/2017
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
12/05/2017
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/09/2016
INPC
INVALIDATION PROCESSED
08/09/2016
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
08/09/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/01/2016
71AG
REGISTERED-SEC.71 ACCEPTED
08/01/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/01/2016
ES71
TEAS SECTION 71 RECEIVED
28/11/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/08/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/08/2015
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
15/07/2015
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
24/03/2015
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
24/07/2014
PLGL
ASSIGNED TO PARALEGAL
24/07/2014
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
23/07/2014
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
04/07/2014
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
30/04/2014
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
04/06/2013
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/02/2013
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
04/10/2012
PLGL
ASSIGNED TO PARALEGAL
04/10/2012
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
04/10/2012
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
28/09/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
28/07/2010
FIMP
FINAL DISPOSITION PROCESSED
28/07/2010
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
28/07/2010
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/07/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
06/04/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/01/2010
PUBO
PUBLISHED FOR OPPOSITION
19/01/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
14/12/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/12/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/12/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/12/2009
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/12/2009
ALIE
ASSIGNED TO LIE
11/12/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/11/2009
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/11/2009
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
06/11/2009
RFNT
REFUSAL PROCESSED BY IB
29/09/2009
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
23/09/2009
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
18/09/2009
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/09/2009
RFRR
REFUSAL PROCESSED BY MPU
04/09/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/09/2009
CNRT
NON-FINAL ACTION WRITTEN
03/09/2009
DOCK
ASSIGNED TO EXAMINER
27/08/2009
MAFR
APPLICATION FILING RECEIPT MAILED
11/08/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/08/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/08/2009
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BELIXOS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.